Minneapolis, MNNCT07718802Now EnrollingIRB Ready

Nephrolithiasis Clinical Trial in Minneapolis, MN

Access cutting-edge nephrolithiasis treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by Children's Hospital of Philadelphia

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access nephrolithiasis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nephrolithiasis treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this nephrolithiasis clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Nephrolithiasis Study in Minneapolis

The aims of the Observational Approach versus Surgical Intervention for Asymptomatic Stone (OASIS) trial are: 1) to determine whether observation compared to upfront surgery results in less healthcare-related life disruption due to kidney stones among children and adults with asymptomatic kidney stones; 2) to identify the groups benefiting the most from each strategy; and 3) to determine the preferences and values informing the choice between observation and upfront surgery.

Sponsor: Children's Hospital of Philadelphia

Who Can Participate

Inclusion Criteria

Individuals age 6 or older
Diagnosis of kidney stone disease (nephrolithiasis)
Asymptomatic, non-obstructive kidney stones measuring 4 to 10 mm (inclusive)
Asymptomatic is defined as the absence of abdominal pain, flank pain, gross hematuria, and nausea and/or vomiting in the last 3 months that in the judgement of the site PI could be attributable to kidney stones.
Non-obstructive is defined as a stone in a renal calyx or stones in multiple renal calyces on CT, ultrasound, and/or x-ray obtained within 6 months of screening.
Informed consent and if appropriate, child assent.
Willingness to be randomized to surgery or observation Note: subjects otherwise eligible who decline randomization may be enrolled in a parallel observational cohort.
Fluent in English or Spanish
Willingness to be audio- and/or video- recorded during interviews

Exclusion Criteria

Untreated hydronephrosis or caliectasis
Pain (e.g., renal colic, abdominal pain) or gross hematuria attributed to kidney stones.
Recurrent symptomatic urinary tract infections (≥3 in 12 months or ≥2 in 6 months). A symptomatic urinary tract infection is defined as having at least one bladder or voiding symptom (e.g., frequency, urgency, dysuria) with bacteriuria (≥105 colony forming units/mL of no more than 2 urinary tract pathogens).
Stone in the renal pelvis, ureter, bladder or urethra
Pregnant females
Solitary kidney, transplant kidney, urinary diversion, medullary sponge kidney
Anatomic abnormality of the kidney (e.g., horseshoe kidney)
Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT07718802) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nephrolithiasis Treatment Options in Minneapolis, MN

If you're searching for nephrolithiasis treatment options in Minneapolis, MN, this clinical trial (NCT07718802) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nephrolithiasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all nephrolithiasis clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Minneapolis, MN

See all ankylosing spondylitis clinical trials recruiting in Minneapolis — not just this study.

Browse Ankylosing Spondylitis Trials in Minneapolis →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsPulmonary Hypertension TrialsKidney Stones TrialsAll Conditions →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN